SYSTEMIC LUPUS ERTHEMATOSUS OR KESTLEMAN’S DISEASE? DIFFICULTIES OF DIAGNOSIS. (CASE REPORT AND REVIEW OF LITERATURE)

1. <div><p>Насонова В. А., Астапенко М.Г. Клиническая ревматология. Руководство для врачей. М., Медицина, 1989.</p><p>Burger! Е.О. Gilchrist G.S., Fairbanks V.F. et al. Intra-abdominal, angiofollicular lymph node hyperplasia (plasma-cell variant) with antierythropoetic factor. Mayo Clin. Proc., 1975,50,542-546.</p><p>Barloli E., Massarelli G., Soggia G., Tanda F. Mullicentric giant lymph node hyperplasia: A hyperimmune syndrome with rapidly progressive course. Am. J. Clin. Pathol. 1980, 73,423-426.</p><p>Bleiwciss I.G. Dumitrescu O.L., Jagirdar J. Angiofollicular lymph node hyperplasia associated with myelofibrosis: Case report and immunological marker studies. Hematol. Oncol., 1988,6,275-284.</p><p>Bertero M-Т. De Maestri М., Caligaris-Cappio F. Cydophospha- mide/eyclosporin-A treatment of multicentric Castleman’s disease with Kaposi's sarcoma. J.Hematol. 2000, 2, scientific correspondence.</p><p>Castleman B., Iverson L„ Menendez V.P. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer, 1956,9,822830.</p><p>Couch W.D. Giant lymph node hyperplasia associated with thrombotic thrombocytopenic purpura. Am. J. Clin. Pathol.. 1980, 74, 340-344.</p><p>S. Ceaserman E., Knowles D.M. Kaposi’s sarcoma - associated herpes virus: A lympholropic human herpes virus associated with Kaposi’s sarcoma, primary effusion lymphonm and mullicentric Castleman's disease. Semin. Diagn. Pathol., 1997, 14, 54-66.</p><p>Dhingra H., Sondhi D., Fleischman J. et al. Castleman’s disease and superior vena cava thrombi: a rare presentation and a review of the literature. Mount Sinai J. Medicine, 2001, 68, 6, 410-416.</p><p>Frizzera G., Banks P.M. Massarelli G., Rosai J. A systemic lym- phoproliferativedisorder with morphologic features of Castleman’s disease: Pathological findings in 15 patients. Am. J. Surg. Pathol. 1983,7,211-231.</p><p>Frizzera G. Castleman’s disease: more questions than answers. Hum. Pathol., 1985, 16, 202-205.</p><p>Frizzera G., Peterson B.A., Bayrd E.D. et al. A systemic lymphop- roliferative disorder with morphologic features of Casllemun's disease: Clinical findings and clinicopathological correlation in l&gt; patients. 5. Clin. Oncol., 1985, 3, 1202-1216.</p><p>Ferreiros J., Gomez L., Mala М.I. et al. Computed tomography in abdominal Casleman’s disease. J. Comput. Assist. Tomogr., 1989, 13.433-466.</p><p>Gianaris P.G., Leestma J.E., Cerullo L.J,, Butler A. Castleman’s disease manifesting in the central nervous system: A case report with immunological studies. Neurosurgery, 1989. 24, 608-613.</p><p>Gerald W., Koslianovasky М., Rosai J. Development of vascular neoplasia in Castleman's disease: Report of seven cases. Am. J. Surg. Pathol., 1990, 14, 603-614.</p><p>Greiner Т., Armitage.1.0., Gross T.G. Atypical lymphoprolilera- tive disease. Hematol., 2000, 1, 133-154.</p><p>Humpherys S.R., Holley K.E., Smith L.H., Mcllrath D.C. Mesenteric angiofollicular lymph node hyperplasia (lymphoid hamartoma) wilh nephrotic syndrome. Mayo Clin. Proc., 1975, 50, 317321.</p><p>Hsieh M.L., Quint L.E., Faust J.M., Turner J.E. Enhancing mediastinal mass al. MR: Castleman's disease. Magn. Reson. Imaging, 1993, 11,599-601.</p><p>Keller A.R., Hochholzer L., Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and othe locations. Cancer, 1972, 29, 670-683.</p><p>Krishanan J. Danon A.D., Frizzera G. Reactive lymphadenopa- thies and atypical lymphoproliferative disorders. Am. J. Clin. Pathol., 1993, 90, 385-396.</p><p>Kirsch C.F., Webb E.M., Webb W.R. Mullicentric Castleman’s disease and POEMS syndrome: CT findings. J. Thorac. Imaging, 1997, 12,75-77.</p><p>Kojuma М., Nakamura S., Itoh H. et al. Systemic lupus erythematosus (SLE) lympliadenopathy presenting histopathologic features of Castleman's disease: clinicopalhologic study of five cases. Pathol. Res. Pract., 1997, 193, 8, 565-71.</p><p>Kojuma M„ Nakamura S., Morishita Y. et al. Reactive follicular hyperplasia in Ihe lymph node lesions from systemic lupus erythematosus patients: a elinico-pathological and immunohislochemi- cal study of 21 cases. Pathol. Int., 2000, 50, 4, 304-312.</p><p>Kumari P., SchechlerG.P.,Saini N. Benalor D.A. Successful treatment of Human Immunodeficiency Virus - related Castleman's disease wilh Interferon-a. Clin. Infect. Dis., 2000, 31. 602-604.</p><p>Lin S.J., Hsueh C., Chao H.C. Localised hyaline vascular type of Castleman's disease mimicking adult-onset Still’s disease (abstract). Clin. Rheumatol., 1999, 18(6), 485-487.</p><p>Menke D.M., Camorinao J.K., Banks P.M. Angiofollicular lymph node hyperplasia: Comparison of unicentric, multicentric, hyaline- vascular and plasma-cell type by morphometric and clinical analysis. Mod. Pathol., 1992, 5. 525-530.</p><p>Moon W.K., Im J.G., Han M.C. Castleman’s disease of the mediastinum: MR imagin features. Clin. Radiol., 1994, 49, 466-468.</p><p>McCarthy M.J., Vukelja S.J., Banks P.M., Weiss R.B. Angiofollicular lymph node hyperplasia (Castleman's disease). Cancer Treat. Rev., 1995,21,291-310.</p><p>Neerhout R.C., Larson W., Mansur P. Mesenteric lymphoid hamartoma associated with hypolerremia, anemia, growth failure and hyperglobulineniia. N. Engl. J. Med., 1969, 280, 922-925.</p><p>Nishimolo N., Kishimoto T„ Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann. Rheum. Dis., 2000, 59(suppl I).121-127.</p><p>Nishi J., Maruyama 1. Increased expression of vascular endothelial growth factor (VEGF) in Castleman’s disease: proposed path- omechanism of vascular proliferation in the alTected lymph node [abstract]. Leuk. Lymphoma, 2000, 38(3-4), 387-394.</p><p>Pavlidis N.A., Skopouli F.N., Bai M.C. et al. A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy. Med. Pediatr. Oncol., 1990, 18, 333-335,</p><p>Palestro G„ Turrini F., Pagano М., Chiusa L. Castleman’s disease. Adv. Clin. Path., 1999, 3, 1-2, 11-22</p><p>Rizzo S.C., Balduini C.L. Gamba G. et al. Castleman’s disease with coagulation defect: A case report. Blut, 1984, 49, 107-109.</p><p>Repetto L., Jaiparkash M.P., Selby P.J., et al. Aggressive angiofollicular lymph node hyperplasia treated with high dose melphalan and autologous bone marrow transplantation. Hematol. Oncol., 1986, 4,213-217.</p><p>Racz P., Tenner-Racz K., Van Volten F. et al. Classification of histopathologial changes of lymph nodes in HIV infection: Significance of Castleman's disease like lymph node lesion concerning IhediagnosisofHlV-l related Kaposi sarcoma. Antibiol. Chemoth- er„ 1991,43, 210-213,</p><p>Reynolds S.P., Gibbs A.R., Weeks R. et al. Massive pleural effusion: An unusual presentation of Castleman’s disease. Eur. Respir. J., 1992, 5, 1150-1153.</p><p>Samuels Т.Н., Hamilton P.A., Ngan B. Mediastinal Castleman’s disease: Demonstration wilh computed tomography and angiography. Can. Assoc. Radiol. J., 1990, 41, 380-383.</p><p>Snead M.P., James J.N., Snead D.R., el al. Orbital lymphomas and Castleman's disease. Eye, 1993, 7, 84-S8.</p><p>Shahidi H„ Myers J.L., Kvale P.A. Castleman’s disease. Mayo. Clin. Proc., 1995, 70, 969-977.</p><p>Simpson R. J„ Hammacher A., Smith D.K., et al. Interleukin-6: structure-funclion relationships. Protein Sci., 1997, 6(5), 929-955.</p><p>Simko R, Nagy K, Lombay B, Kiss A, Minik K, Lukacs VH, Vamosi. Multicentric Castleman disease and systemic lupus erythematosus phenotype in a boy with Klinefelter syndrome: long-term disease stabilization with interferon therapy, J. Pediatr. Hematol. Oncol. 2000, 22(2), 180-183.</p><p>Tan E.M., Cohen A S., Fries J.P. et al. The 19S2 revised criteria for classification of systemic lupus erythematosus (SLE). Arthr. Rheum., 1982, 25, 1271-1277.</p><p>Weisenburger D.D., Nathwani B.N., Winberg C.D., Rappaport H. Multicentric angiofollicular lymph node hyperplasia: A clinico- pathological study of 16 cases. Hum. Pathol., 1985, 16, 162-172.</p><p>York J.C., Taylor C.R., Lukes R.J., Monoklonality in giant lymph node hyperplasia [abstract]. Lab. Inv., 1981, 44, 77A.</p><p>Yoshizaki K., Nishimoto N., Mihara М., Kishimoto T. Therapy of RA by blocking IL-6 signal transduction with humanized nnti- 1L-6 receptor antibody. Springer Sem. Immunopathol, 1998, 20, 247-259.</p><p>Zarate-Osomo A., Medeiros L.J. Danon A.D. el al. Hodgkin's disease with coexistent Castleman-like histologic features: A report of three cases. Arch. Pathol. Lab. Med., 1994, 118, 270-274.</p></div><br />